相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Simultaneous delivery of anti-miRNA and docetaxel with supramolecular self-assembled chitosome for improving chemosensitivity of triple negative breast cancer cells
Xianfu Sun et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2021)
A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells
Maxine Umeh-Garcia et al.
CANCER RESEARCH (2020)
Dual delivery nanoscale device for miR-451 and adriamycin co-delivery to combat multidrug resistant in bladder cancer
Shuguang Wei et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Regulatory Mechanism of MicroRNA Expression in Cancer
Zainab Ali Syeda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Role of microRNAs in remodeling the tumor microenvironment (Review)
Zhaoji Pan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer
Arefeh Kardani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
MicroRNAs in tumor immunity: functional regulation in tumor-associated macrophages
Chong Chen et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2020)
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
Haiyang Zhang et al.
MOLECULAR CANCER (2020)
Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer
Matthew G. Costales et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer
Xiao-Xiao Peng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
The Optimal Outcome of Suppressing Ewing Sarcoma Growth in vivo With Biocompatible Bioengineered miR-34a-5p Prodrug
Dai-Feng Li et al.
FRONTIERS IN ONCOLOGY (2020)
Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer
Gaofeng Liang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
The role of miR-34 in cancer drug resistance
Sanaz Naghizadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition
Prathibha Kirave et al.
Oncotarget (2020)
CD59 receptor targeted delivery of miRNA-1284 and cisplatin-loaded liposomes for effective therapeutic efficacy against cervical cancer cells
Li Wang et al.
AMB EXPRESS (2020)
miR-29b and retinoic acid co-delivery: a promising tool to induce a synergistic antitumoral effect in non-small cell lung cancer cells
Mariana Magalhaes et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer
Qing Xi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Ultrasound-Mediated Co-Delivery of miR-34a and sPD-1 Complexed with Microbubbles for Synergistic Cancer Therapy
Yu-e Qin et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Upregulated MELK Leads to Doxorubicin Chemoresistance and M2 Macrophage Polarization via the miR-34a/JAK2/STAT3 Pathway in Uterine Leiomyosarcoma
Zhiwei Zhang et al.
FRONTIERS IN ONCOLOGY (2020)
MiR-145 in cancer therapy resistance and sensitivity: A comprehensive review
Wenxiu Xu et al.
CANCER SCIENCE (2020)
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics
Diana Bautista-Sanchez et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Development of MicroRNAs as Potential Therapeutics against Cancer
Noraini Abd-Aziz et al.
JOURNAL OF ONCOLOGY (2020)
Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages
Xiaoli Yao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of Drugs
Tommaso Felicetti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Advances in oligonucleotide drug delivery
Thomas C. Roberts et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Efficiency and Target Derepression of Anti-miR-92a: Results of a First in Human Study
Wesley Tyler Abplanalp et al.
NUCLEIC ACID THERAPEUTICS (2020)
Dual Regulation of miR-34a and Notch Signaling in Triple-Negative Breast Cancer by Antibody/miRNA Nanocarriers
Danielle M. Valcourt et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Mesenchymal Stem Cell-Secreted Exosome Promotes Chemoresistance in Breast Cancer via Enhancing miR-21-5p-Mediated S100A6 Expression
Tao Luo et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression
Liang Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Brain-Targeted Delivery of Pre-miR-29b Using Lactoferrin-Stearic Acid-Modified-Chitosan/Polyethyleneimine Polyplexes
Patricia Pereira et al.
PHARMACEUTICALS (2020)
A general fragment-based approach to identify and optimize bioactive ligands targeting RNA
Blessy M. Suresh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Combinatorial miRNA-34a replenishment and irinotecan delivery via auto-fluorescent polymeric hybrid micelles for synchronous colorectal cancer theranostics
Yunhao Li et al.
BIOMATERIALS SCIENCE (2020)
Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy
Xiaofei Xin et al.
SCIENCE ADVANCES (2020)
Efficient co-delivery of microRNA 21 inhibitor and doxorubicin to cancer cells using core-shell tecto dendrimers formed via supramolecular host-guest assembly
Cong Song et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Huntington's Disease Clinical Trials Corner: April 2020
Filipe B. Rodrigues et al.
JOURNAL OF HUNTINGTONS DISEASE (2020)
Dual responsive micelles capable of modulating miRNA-34a to combat taxane resistance in prostate cancer
Feng Lin et al.
BIOMATERIALS (2019)
A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo
Amirhossein Bahreyni et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR-23a-3p and Up-regulate Programmed Death Ligand 1 Expression in Macrophages
Jiatao Liu et al.
HEPATOLOGY (2019)
Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells
Adriana M. Ledo et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma
Seyed Nasrollah Tabatabaei et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype
Xiaolan Zhu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin
Matthew G. Costales et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift
Jung Eun Park et al.
ONCOGENE (2019)
Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype
Ann-Christin Frank et al.
NATURE COMMUNICATIONS (2019)
Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing
Audrey Vautrin et al.
SCIENTIFIC REPORTS (2019)
ROS-Responsive Polymeric Micelles for Triggered Simultaneous Delivery of PLK1 Inhibitor/miR-34a and Effective Synergistic Therapy in Pancreatic Cancer
Xiaofei Xin et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo
My-Anh Nguyen et al.
ACS NANO (2019)
Exosome-derived miR-27a produced by PSC-27 cells contributes to prostate cancer chemoresistance through p53
Zhigang Cao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
The Potential for microRNA Therapeutics and Clinical Research
Johora Hanna et al.
FRONTIERS IN GENETICS (2019)
Creatine based polymer for codelivery of bioengineered MicroRNA and chemodrugs against breast cancer lung metastasis
Jieni Xu et al.
BIOMATERIALS (2019)
ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model
Chi-Ling Chiang et al.
BLOOD (2019)
Hypoxic Glioma Cell-Secreted Exosomal miR-301a Activates Wnt/β-catenin Signaling and Promotes Radiation Resistance by Targeting TCEAL7
Xiao Yue et al.
MOLECULAR THERAPY (2019)
Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages
Hao-Yu Chuang et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Modulation of the dual-faced effects of miR-141 with chitosan/miR-141 nanoplexes in breast cancer cells
Kubra Kaban et al.
JOURNAL OF GENE MEDICINE (2019)
Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia
Saravanan Ganesan et al.
CELL DEATH & DISEASE (2019)
pH-Responsive PEG-Shedding and Targeting Peptide-Modified Nanoparticles for Dual-Delivery of Irinotecan and microRNA to Enhance Tumor-Specific Therapy
Vivian Juang et al.
SMALL (2019)
MicroRNA-A Tumor Trojan Horse for Tumor-Associated Macrophages
Shahzad Nawaz Syed et al.
CELLS (2019)
Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer
Metin Uz et al.
JOURNAL OF CONTROLLED RELEASE (2019)
A Molecular Targeted Immunotherapeutic Strategy for Ulcerative Colitis via Dual-targeting Nanoparticles Delivering miR-146b to Intestinal Macrophages
Feihong Deng et al.
JOURNAL OF CROHNS & COLITIS (2019)
Delivery of Liver-Specific miRNA-122 Using a Targeted Macromolecular Prodrug toward Synergistic Therapy for Hepatocellular Carcinoma
Qjan Ning et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
The Natural Product Butylcycloheptyl Prodiginine Binds Pre-miR-21, Inhibits Dicer-Mediated Processing of Pre-miR-21, and Blocks Cellular Proliferation
Joe S. Matarlo et al.
CELL CHEMICAL BIOLOGY (2019)
Multifunctional Gold Nanoparticles Overcome MicroRNA Regulatory Network Mediated-Multidrug Resistant Leukemia
Rong Deng et al.
SCIENTIFIC REPORTS (2019)
Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs
Dinh-Duc Nguyen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
CRISPR/Cas9-mediated noncoding RNA editing in human cancers
Jie Yang et al.
RNA BIOLOGY (2018)
Enhanced Chemotherapeutic Efficacy of Paclitaxel Nanoparticles Co-delivered with MicroRNA-7 by Inhibiting Paclitaxel-Induced EGFR/ERK pathway Activation for Ovarian Cancer Therapy
Xiaojuan Cui et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Stimuli-Responsive Nanocarrier for Co-delivery of MiR-31 and Doxorubicin To Suppress High MtEF4 Cancer
Fang Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy
Min Li et al.
ACTA BIOMATERIALIA (2018)
Platinated graphene oxide: A nanoplatform for efficient gene-chemo combination cancer therapy
Peng Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Non-viral based miR delivery and recent developments
Annalise Elizabeth Labatut et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
miR-301a plays a pivotal role in hypoxia-induced gemcitabine resistance in pancreatic cancer
Guangtao Luo et al.
EXPERIMENTAL CELL RESEARCH (2018)
MiR-21-mediated Metabolic Alteration of Cancer-associated Fibroblasts and Its Effect on Pancreatic Cancer Cell Behavior
Shuo Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Honokiol suppresses proliferation and induces apoptosis via regulation of the miR-21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells
Jiexiang Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Using microRNA Networks to Understand Cancer
Mihnea Dragomir et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR-424-3p and targeting PTEN/PI3K/Akt pathway
Chunya Lu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8+ T cell fates
Tianxia Guan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Small Molecule Inhibition of MicroRNA miR-21 Rescues Chemosensitivity of Renal-Cell Carcinoma to Topotecan
Yuta Naro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy
Pui Yan Ho et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer
Lulin Zhang et al.
ONCOLOGY RESEARCH (2018)
Anti-miRNA oligonucleotides: A comprehensive guide for design
Joana Filipa Lima et al.
RNA BIOLOGY (2018)
MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
Yaming Li et al.
CELL DEATH & DISEASE (2018)
miR-130a and miR-145 reprogram Gr-1+CD11b+ myeloid cells and inhibit tumor metastasis through improved host immunity
Hiroki Ishii et al.
NATURE COMMUNICATIONS (2018)
UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy
Lizhou Lin et al.
THERANOSTICS (2018)
Triple therapy of hepatocellular carcinoma with microRNA-122 and doxorubicin co-loaded functionalized gold nanocages
Shengnan Huang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2018)
Function of miR-146a-5p in Tumor Cells As a Regulatory Switch between Cell Death and Angiogenesis: Macrophage Therapy Revisited
Elina Simanovich et al.
FRONTIERS IN IMMUNOLOGY (2018)
Epigallocatechin-3-gallate inhibited cancer stem cell-like properties by targeting hsa-mir-485-5p/RXRα in lung cancer
Pan Jiang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Ph 1 study of MRG-106, an inhibitor of miR-155, in CTCL.
Francine M. Foss et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells
Pan Jiang et al.
MOLECULAR CARCINOGENESIS (2018)
Building of neomycin-nucleobase-amino acid conjugates for the inhibition of oncogenic miRNAs biogenesis
Duc Duy Vo et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2018)
OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers
Paloma del C. Monroig-Bosque et al.
SCIENTIFIC REPORTS (2018)
Enzymatically synthesized poly(amino-co-ester) polyplexes for systemic delivery of pcDNA-miRNA-214 to suppress colorectal cancer liver metastasis
Hui-yan Luo et al.
JOURNAL OF MATERIALS CHEMISTRY B (2018)
Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p
Yao-yin Li et al.
EBIOMEDICINE (2018)
Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis
Xin Ge et al.
CELL DEATH & DISEASE (2018)
miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a/IL-1ra pathway in mouse breast cancer
Wei Wang et al.
ONCOGENESIS (2018)
Engineering CAR-T Cells for Improved Function Against Solid Tumors
Michael A. Morgan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Target RNAs Strike Back on MicroRNAs
Federico Fuchs Wightman et al.
FRONTIERS IN GENETICS (2018)
Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs
Sai Pradeep Velagapudi et al.
CELL CHEMICAL BIOLOGY (2018)
miR-155 in cancer drug resistance and as target for miRNA-based therapeutics
Recep Bayraktar et al.
CANCER AND METASTASIS REVIEWS (2018)
Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells
Berrin Kucukturkmen et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2018)
Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells
Berrin Kucukturkmen et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2017)
Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
Peiming Zheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Nico van Zandwijk et al.
LANCET ONCOLOGY (2017)
Calcium phosphate-polymer hybrid nanoparticles for enhanced triple negative breast cancer treatment via co-delivery of paclitaxel and miR-221/222 inhibitors
Zilan Zhou et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes
Can Liu et al.
NATURE COMMUNICATIONS (2017)
Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer
Qian-Qian Li et al.
ONCOTARGET (2017)
Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells
Wenying Huo et al.
JOURNAL OF CANCER (2017)
Significance of microRNAs in Androgen Signaling and Prostate Cancer Progression
Ken-ichi Takayama et al.
CANCERS (2017)
Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer
Li Zhang et al.
SCIENTIFIC REPORTS (2017)
LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts
Aleksander Touznik et al.
SCIENTIFIC REPORTS (2017)
Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine
Nan Hu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research
Guillermo Aquino-Jarquin
CANCER RESEARCH (2017)
A Macrocyclic Peptide Ligand Binds the Oncogenic MicroRNA-21 Precursor and Suppresses Dicer Processing
Matthew D. Shortridge et al.
ACS CHEMICAL BIOLOGY (2017)
Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy
Yaqing Li et al.
CANCER SCIENCE (2017)
miR-142-5p regulates tumor cell PD-Ll expression and enhances anti-tumor immunity
Long Jia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer
Di Wen et al.
CANCER RESEARCH (2017)
miRNases: Novel peptide-oligonucleotide bioconjugates that silence miR-21 in lymphosarcoma cells
Olga A. Patutina et al.
BIOMATERIALS (2017)
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
Jun Wei et al.
NEURO-ONCOLOGY (2016)
Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer
C. Coarfa et al.
ONCOGENE (2016)
Anticancer function of α-solanine in lung adenocarcinoma cells by inducing microRNA-138 expression
Furui Zhang et al.
TUMOR BIOLOGY (2016)
Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF- and miR23a transfer
Guy Berchem et al.
ONCOIMMUNOLOGY (2016)
Reprogramming carcinoma associated fibroblasts by AC1MMYR2 impedes tumor metastasis and improves chemotherapy efficacy
Yu Ren et al.
CANCER LETTERS (2016)
Sponges against miR-19 and miR-155 reactivate the p53-Socs1 axis in hematopoietic cancers
Lian Mignacca et al.
CYTOKINE (2016)
Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic
Nadiya M. Teplyuk et al.
EMBO MOLECULAR MEDICINE (2016)
Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy
Chong Yao et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy
Yu Ren et al.
JOURNAL OF CONTROLLED RELEASE (2016)
miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance
Merve Mutlu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Triptolide reduces proliferation and enhances apoptosis of human non-small cell lung cancer cells through PTEN by targeting miR-21
Xiaofang Li et al.
MOLECULAR MEDICINE REPORTS (2016)
Autophagy inhibition upregulates CD4+ tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation
Paul Zarogoulidis et al.
MOLECULAR ONCOLOGY (2016)
Delivery of miR-200c Mimic with Poly(amido amine) CXCR4 Antagonists for Combined Inhibition of Cholangiocarcinoma Cell Invasiveness
Ying Xie et al.
MOLECULAR PHARMACEUTICS (2016)
Combination wt-p53 and MicroRNA-125b Transfection in a Genetically Engineered Lung Cancer Model Using Dual CD44/EGFR-targeting Nanoparticles
Meghna Talekar et al.
MOLECULAR THERAPY (2016)
Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy
Shengpeng Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
EGF receptor targeted lipo-oligocation polyplexes for antitumoral siRNA and miRNA delivery
Katharina Mueller et al.
NANOTECHNOLOGY (2016)
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
R. Rupaimoole et al.
ONCOGENE (2016)
Design of a small molecule against an oncogenic noncoding RNA
Sai Pradeep Velagapudi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer
Glen Reid et al.
EPIGENOMICS (2016)
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer
Sherry Y. Wu et al.
NATURE COMMUNICATIONS (2016)
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma
Hui-Ying Xue et al.
ONCOTARGET (2016)
Anti-tumor Efficiency of Lipid-coated Cisplatin Nanoparticles Co-loaded with MicroRNA-375
Tan Yang et al.
THERANOSTICS (2016)
Therapeutics in Cancer - An Emerging Concept
Maitri Y. Shah et al.
EBIOMEDICINE (2016)
CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo
Hong Chang et al.
SCIENTIFIC REPORTS (2016)
The role of MicroRNAs in human cancer
Yong Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
MiR 221/222 as New Players in Tamoxifen Resistance
Nafiseh Sadat Alamolhodaei et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Small Molecule Inhibition of miR-544 Biogenesis Disrupts Adaptive Responses to Hypoxia by Modulating ATM-mTOR Signaling
Christopher L. Haga et al.
ACS CHEMICAL BIOLOGY (2015)
Polymer Nanoparticles Mediated Codelivery of AntimiR-10b and AntimiR-21 for Achieving Triple Negative Breast Cancer Therapy
Rammohan Devulapally et al.
ACS NANO (2015)
Small molecule compounds targeting miRNAs for cancer therapy
Paloma del C. Monroig et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Combination of microRNA therapeutics with small-molecule anticancer drugs: Mechanism of action and co-delivery nanocarriers
Xin Dai et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Yunching Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Antisense oligonucleotides in therapy for neurodegenerative disorders
Melvin M. Evers et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Discovery of 4-benzoylamino-N-(prop-2-yn-1-yl)benzamides as novel microRNA-21 inhibitors
Cong-shan Jiang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Aryl amide small-molecule inhibitors of microRNA miR-21 function
Yuta Naro et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors
Amy L. Walz et al.
CANCER CELL (2015)
AC1MMYR2 impairs high dose paclitaxel-induced tumor metastasis by targeting miR-21/CDK5 axis
Yu Ren et al.
CANCER LETTERS (2015)
Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts
Wenjing Pang et al.
CANCER SCIENCE (2015)
Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation
Carlos Stahlhut et al.
CELL CYCLE (2015)
Simultaneous delivery of therapeutic antagomirs with paclitaxel for the management of metastatic tumors by a pH-responsive anti-microbial peptide-mediated liposomal delivery system
Qianyu Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2015)
MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma
Pedro M. Costa et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Dual loading miR-218 mimics and Temozolomide using AuCOOH@FA-CS drug delivery system: promising targeted antitumor drug delivery system with sequential release functions
Li Fan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
Kishore B. Challagundla et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
Guoyan Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
MicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy Efficacy
Maddalena Mognato et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2015)
Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells
Rammohan Devulapally et al.
MOLECULAR PHARMACEUTICS (2015)
MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2 l
Pu Zhang et al.
TOXICOLOGY LETTERS (2015)
The Landscape of long noncoding RNA classification
Georges St Laurent et al.
TRENDS IN GENETICS (2015)
Epigenetic silencing of miR-145-5p contributes to brain metastasis
Sara Donzelli et al.
ONCOTARGET (2015)
Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level
Jessian L. Munoz et al.
ONCOTARGET (2015)
Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
Donato Cosco et al.
SCIENTIFIC REPORTS (2015)
MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges
Huiyin Lan et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
Kishore B. Challagundla et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
Guoyan Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
Christopher J. Cheng et al.
NATURE (2015)
Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization
Wei-Peng Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
Targeting the Production of Oncogenic MicroRNAs with Multimodal Synthetic Small Molecules
Duc Duy Vo et al.
ACS CHEMICAL BIOLOGY (2014)
MicroRNAs in Cancer
Gianpiero Di Leva et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
HypoxamiRs and Cancer: From Biology to Targeted Therapy
Harriet E. Gee et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer
Anupama Mittal et al.
BIOMATERIALS (2014)
Hyaluronic acid-chitosan nanoparticles for co-delivery of M1R-34a and doxorubicin in therapy against triple negative breast cancer
Xiongwei Deng et al.
BIOMATERIALS (2014)
Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma
Xiaomin Qian et al.
BIOMATERIALS (2014)
The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer
Kelly A. Avery-Kiejda et al.
BMC CANCER (2014)
A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling
Yuxian Song et al.
CANCER BIOLOGY & THERAPY (2014)
Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth
Yuan Yin et al.
CELL RESEARCH (2014)
Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203
Min Zhou et al.
CELLULAR IMMUNOLOGY (2014)
miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents
Volker Baumann et al.
FUTURE MEDICINAL CHEMISTRY (2014)
A microRNA 221-and 222-Mediated Feedback Loop Maintains Constitutive Activation of NFκB and STAT3 in Colorectal Cancer Cells
Sanhong Liu et al.
GASTROENTEROLOGY (2014)
Reciprocal Regulation of MicroRNA-122 and c-Myc in Hepatocellular Cancer: Role of E2F1 and Transcription Factor Dimerization Partner 2
Bo Wang et al.
HEPATOLOGY (2014)
Functional microRNAs and target sites are created by lineage-specific transposition
Ryan M. Spengler et al.
HUMAN MOLECULAR GENETICS (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression
Sanjun Shi et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Designing a gold nanoparticle-based nanocarrier for microRNA transfection into the prostate and breast cancer cells
Asli Ekin et al.
JOURNAL OF GENE MEDICINE (2014)
Propofol exerts anti-hepatocellular carcinoma by microvesicle-mediated transfer of miR-142-3p from macrophage to cancer cells
Jian Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
Maria Angelica Cortez et al.
MOLECULAR THERAPY (2014)
Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine
Hui Yi Xue et al.
NANOMEDICINE (2014)
Sequence-based design of bioactive small molecules that target precursor microRNAs
Sai Pradeep Velagapudi et al.
NATURE CHEMICAL BIOLOGY (2014)
Miravirsen (SPC3649) can inhibit the biogenesis of miR-122
Luca F. R. Gebert et al.
NUCLEIC ACIDS RESEARCH (2014)
miR-Synth: a computational resource for the design of multi-site multi-target synthetic miRNAs
Alessandro Lagana et al.
NUCLEIC ACIDS RESEARCH (2014)
Impaired DICER1 function promotes stemness and metastasis in colon cancer
M. S. Iliou et al.
ONCOGENE (2014)
MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer
Yutaka Naito et al.
ONCOLOGY REPORTS (2014)
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
Maria Teresa Di Martino et al.
PLOS ONE (2014)
Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes
Rammohan Devulapally et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2014)
Hypoxia-induced miR-424 decreases tumor sensitivity to chemotherapy by inhibiting apoptosis
D. Zhang et al.
CELL DEATH & DISEASE (2014)
Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles
Qin Lin et al.
BIOMATERIALS (2013)
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway
Yonghui Li et al.
BLOOD (2013)
AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial-Mesenchymal Transition and Suppresses Tumor Growth and Progression
Zhendong Shi et al.
CANCER RESEARCH (2013)
Downregulation of microRNA-515-5p by the Estrogen Receptor Modulates Sphingosine Kinase 1 and Breast Cancer Cell Proliferation
Filipa G. Pinho et al.
CANCER RESEARCH (2013)
Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling
Yonggang Li et al.
CARCINOGENESIS (2013)
Stimulus-responsive nanopreparations for tumor targeting
Lin Zhu et al.
INTEGRATIVE BIOLOGY (2013)
Construction of circular miRNA sponges targeting miR-21 or miR-221 and demonstration of their excellent anticancer effects on malignant melanoma cells
Yuchen Liu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Silencing of miR-21 by locked nucleic acid-lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death
A. Griveau et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Chitosan-based siRNA delivery systems
Heloise Ragelle et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Shin-ichiro Ohno et al.
MOLECULAR THERAPY (2013)
MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines
Pasqualino de Antonellis et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2013)
Treatment of HCV Infection by Targeting MicroRNA
Harry L. A. Janssen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Functionalized Graphene Oxide Mediated Adriamycin Delivery and miR-21 Gene Silencing to Overcome Tumor Multidrug Resistance In Vitro
Feng Zhi et al.
PLOS ONE (2013)
Tumour angiogenesis regulation by the miR-200 family
Chad V. Pecot et al.
NATURE COMMUNICATIONS (2013)
A MicroRNA196a2☆ and TP63 Circuit Regulated by Estrogen Receptor-α and ERK2 that Controls Breast Cancer Proliferation and Invasiveness Properties
Kyuri Kim et al.
HORMONES & CANCER (2013)
Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment
Pedro M. Costa et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
The Tuberculosis Drug Streptomycin as a Potential Cancer Therapeutic: Inhibition of miR-21 Function by Directly Targeting Its Precursor
Debojit Bose et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Causes and Consequences of MicroRNA Dysregulation
Marilena V. Iorio et al.
CANCER JOURNAL (2012)
A universal activator of microRNAs identified from photoreaction products
Xuejiao Chen et al.
CHEMICAL COMMUNICATIONS (2012)
Sequence-Dependent Synergistic Inhibition of Human Glioma Cell Lines by Combined Temozolomide and miR-21 Inhibitor Gene Therapy
Xiaomin Qian et al.
MOLECULAR PHARMACEUTICS (2012)
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320
A. Bronisz et al.
NATURE CELL BIOLOGY (2012)
Dysregulated Expression of Dicer and Drosha in Breast Cancer
Min Yan et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles
Amanda Tivnan et al.
PLOS ONE (2012)
Insights into the potential use of microRNAs as biomarker in cancer
Mohammad Iffat Kabir Anindo et al.
INTERNATIONAL JOURNAL OF SURGERY (2012)
Computational analysis of noncoding RNAs
Stefan Washietl et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2012)
Targeting Immune Checkpoints Releasing the Restraints on Anti-Tumor Immunity for Patients With Melanoma
Michael A. Postow et al.
CANCER JOURNAL (2012)
Curcumin Modulates MicroRNA-203-Mediated Regulation of the Src-Akt Axis in Bladder Cancer
Sharanjot Saini et al.
CANCER PREVENTION RESEARCH (2011)
miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress
Jiening Xiao et al.
EMBO JOURNAL (2011)
p53 downregulates Down syndrome-associated DYRK1A through miR-1246
Yu Zhang et al.
EMBO REPORTS (2011)
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer
Konstantin J. Dedes et al.
EUROPEAN JOURNAL OF CANCER (2011)
MicroRNA therapeutics
J. A. Broderick et al.
GENE THERAPY (2011)
MicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1α Activity during Prolonged Hypoxia
Ulrike Bruning et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Microvesicle-mediated RNA Molecule Delivery System Using Monocytes/Macrophages
Yukihiro Akao et al.
MOLECULAR THERAPY (2011)
Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice
Phong Trang et al.
MOLECULAR THERAPY (2011)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
MicroRNAs: miRRORS of health and disease
Monty Montano
TRANSLATIONAL RESEARCH (2011)
Small RNA and transcriptional upregulation
Victoria Portnoy et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2011)
Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth
Li Xu Yan et al.
BREAST CANCER RESEARCH (2011)
miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells
Haibo Zhou et al.
BLOOD (2010)
Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells
Leina Ma et al.
CANCER BIOLOGY & THERAPY (2010)
microRNA Signature and Expression of Dicer and Drosha Can Predict Prognosis and Delineate Risk Groups in Neuroblastoma
Ruey-Jen Lin et al.
CANCER RESEARCH (2010)
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Jason F. Wiggins et al.
CANCER RESEARCH (2010)
The MicroRNA Spectrum in 12 Body Fluids
Jessica A. Weber et al.
CLINICAL CHEMISTRY (2010)
Co-delivery of as-miR-21 and 5-FU by Poly(amidoamine) Dendrimer Attenuates Human Glioma Cell Growth in Vitro
Yu Ren et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2010)
Nanomedicine based approaches for the delivery of siRNA in cancer
B. Ozpolat et al.
JOURNAL OF INTERNAL MEDICINE (2010)
MicroRNA Cluster 221-222 and Estrogen Receptor α Interactions in Breast Cancer
Gianpiero Di Leva et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
Kotaro Sasaki et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Yunching Chen et al.
MOLECULAR THERAPY (2010)
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia
Konstantinos J. Mavrakis et al.
NATURE CELL BIOLOGY (2010)
Regression of murine lung tumors by the let-7 microRNA
P. Trang et al.
ONCOGENE (2010)
Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma
M. A. T. Hildebrandt et al.
ONCOGENE (2010)
A Direct Comparison of Anti-microRNA Oligonucleotide Potency
Kim A. Lennox et al.
PHARMACEUTICAL RESEARCH (2010)
P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis
Munekazu Yamakuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MicroRNA sponges: Progress and possibilities
Margaret S. Ebert et al.
RNA (2010)
MicroRNAs and cancer: Current state and future perspectives in urologic oncology
Annika Schaefer et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
MicroRNAs: Novel regulators in the hallmarks of human cancer
Kai Ruan et al.
CANCER LETTERS (2009)
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Janaiah Kota et al.
CELL (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
MiR-34, SIRT1 and p53 The feedback loop
Munekazu Yamakuchi et al.
CELL CYCLE (2009)
MicroRNA-155 Regulates Inflammatory Cytokine Production in Tumor-associated Macrophages via Targeting C/EBPβ
Min He et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
MicroRNAs and cancer-new paradigms in molecular oncology
Massimo Negrini et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman et al.
GENOME RESEARCH (2009)
Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation
Xin Huang et al.
MOLECULAR CELL (2009)
Modulation of microRNA processing by p53
Hiroshi I. Suzuki et al.
NATURE (2009)
A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity
Jesper B. Bramsen et al.
NUCLEIC ACIDS RESEARCH (2009)
Commentary on Circulating microRNAs as stable blood-based markers for cancer detection
Adam S. Kibel
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Small-molecule inhibitors of microRNA miR-21 function
Kiranmai Gumireddy et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
Charles H. Lawrie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
The let-7 microRNA reduces tumor growth in mouse models of lung cancer
Aurora Esquela-Kerscher et al.
CELL CYCLE (2008)
Enhancement of RNAi by a small molecule antibiotic enoxacin
Qiangzhe Zhang et al.
CELL RESEARCH (2008)
Detection and characterization of placental MicroRNAs in maternal plasma
Stephen S. C. Chim et al.
CLINICAL CHEMISTRY (2008)
Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer
U. Lehmann et al.
JOURNAL OF PATHOLOGY (2008)
MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation
Ulf Andersson Orom et al.
MOLECULAR CELL (2008)
Cancer complexity slows quest for cure
Erika Check Hayden
NATURE (2008)
LNA-mediated microRNA silencing in non-human primates
Joacim Elmen et al.
NATURE (2008)
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
Desiree Bonci et al.
NATURE MEDICINE (2008)
The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice
Neri Mercatelli et al.
PLOS ONE (2008)
MiR-15a and miR-16-1 cluster functions in human leukemia
George A. Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A microRNA DNA methylation signature for human cancer metastasis
Amaia Lujambio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A role for microRNAs in the development of the immune system and in the pathogenesis of cancer
Chryssa Kanellopoulou et al.
SEMINARS IN CANCER BIOLOGY (2008)
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver
Joacim Elmen et al.
NUCLEIC ACIDS RESEARCH (2008)
The microRNA.org resource: targets and expression
Doron Betel et al.
NUCLEIC ACIDS RESEARCH (2008)
Widespread microRNA repression by Myc contributes to tumorigenesis
Tsung-Cheng Chang et al.
NATURE GENETICS (2008)
A microRNA component of the p53 tumour suppressor network
Lin He et al.
NATURE (2007)
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Tsung-Cheng Chang et al.
MOLECULAR CELL (2007)
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis
Nina Raver-Shapira et al.
MOLECULAR CELL (2007)
Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics
Jennifer A. MacDiarmid et al.
CANCER CELL (2007)
MicroRNAs and chromosomal abnormalities in cancer cells
G. A. Calin et al.
ONCOGENE (2006)
Epigenetic activation of tumor suppressor microRNAs in human cancer cells
Yoshimasa Saito et al.
CELL CYCLE (2006)
Extensive post-transcriptional regulation of microRNAs and its implications for cancer
J. Michael Thomson et al.
GENES & DEVELOPMENT (2006)
microRNAs exhibit high frequency genomic alterations in human cancer
Lin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
Yoshimasa Saito et al.
CANCER CELL (2006)
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster
Michael Dews et al.
NATURE GENETICS (2006)
Improved targeting of miRNA with antisense oligonucleotides
Scott Davis et al.
NUCLEIC ACIDS RESEARCH (2006)
A microRNA cluster as a target of genomic amplification in malignant lymphoma
H Tagawa et al.
LEUKEMIA (2005)
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation
Y Hayashita et al.
CANCER RESEARCH (2005)
c-Myc-regulated microRNAs modulate E2F1 expression
KA O'Donnell et al.
NATURE (2005)
Combinatorial microRNA target predictions
A Krek et al.
NATURE GENETICS (2005)
Overexpression of Exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs
R Yi et al.
RNA (2005)
Reduced expression of Dicer associated with poor prognosis in lung cancer patients
Y Karube et al.
CANCER SCIENCE (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
In vivo characteristics of cationic liposomes as delivery vectors for gene therapy
SAL Audouy et al.
PHARMACEUTICAL RESEARCH (2002)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
分享论文
